» Articles » PMID: 19304583

Subclinical Keratoconus and Inflammatory Molecules from Tears

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2009 Mar 24
PMID 19304583
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Tissue degradation in corneal thinning disorders, such as keratoconus (KC), involves the expression of inflammatory mediators. The purpose of this study was to determine the levels of proinflammatory cytokines and matrix metalloproteinase 9 (MMP-9) in tears from both eyes of unilateral keratoconus (KC) patients.

Methods: Thirty patients diagnosed as having asymmetrical KC (30 KC eyes, and 30 subclinical KC eyes) and 20 normal control subjects (one eye) were studied in a prospective, cross-sectional study. Keratoconus screening programmes were performed on these participants. Ten microlitres of tears was collected from each eye. The concentrations of cytokines (interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha)) and MMP-9 were measured by ELISA.

Results: Mean values for IL-6 levels were similar in KC and subclinical KC samples (5.5 (4.9 to 6.9) vs 5.7 (4.5 to 6.2) pg/ml, p = 0.131), but significantly higher in relation to the control group (2.2 (1.0 to 4.1) pg/ml, p<0.0001). Significant differences were found in TNF-alpha levels between KC and subclinical KC eyes (5.4 (4.1 to 6.8) vs 4.8 (4.2 to 6.0) pg/ml, p = 0.032) and control group (1.8 (1.5 to 2.3) pg/ml, p<0.0001). Increased values of MMP-9 were found in KC (59.4 (50.6 to 66.1) ng/ml) vs subclinical KC eye (7.0 (4.8 to 8.6) ng/ml) (p<0.0001). MMP-9 levels in the control group (6.1 (3.9 to 8.3) ng/ml) and subclinical KC were similar (p = 0.203).

Conclusions: IL-6 and TNF-alpha are overexpressed in the tears of subclinical and KC eyes. Increased MMP-9 levels were found only in the KC eye. These results indicate that the pathogenesis of KC may involve chronic inflammatory events.

Citing Articles

Untargeted Tear Proteomics in a Large South-Asian Cohort Reveals Inflammatory Signaling, ECM Remodeling, and Altered Metabolism in Keratoconus.

Kannan R, Shetty R, Panigrahi T, Koh S, Khamar P, Deshpande V Invest Ophthalmol Vis Sci. 2025; 66(2):60.

PMID: 39992672 PMC: 11878249. DOI: 10.1167/iovs.66.2.60.


Classification of Histologically Proven Inflammation in Clinically Inactive Corneal Scars: Implications for Graft Outcomes After Penetrating Keratoplasty.

Schliffka M, Siegel H, Auw-Haedrich C, van Oterendorp C, Boehringer D, Reinhard T J Clin Med. 2025; 14(2).

PMID: 39860466 PMC: 11765851. DOI: 10.3390/jcm14020461.


Evaluation of Responses to Questions About Keratoconus Using ChatGPT-4.0, Google Gemini and Microsoft Copilot: A Comparative Study of Large Language Models on Keratoconus.

Demir S Eye Contact Lens. 2024; 51(3):e107-e111.

PMID: 39629721 PMC: 11850007. DOI: 10.1097/ICL.0000000000001158.


Relationship of Inflammatory Mediators (Interleukin and Cortisol Concentrations) with Corneal Epithelial Quantifiable Metrics.

Santhiago M, Stival L, Araujo D, Antunes-Foschini R, Toledo M, Nunes I Ophthalmol Sci. 2024; 5(1):100624.

PMID: 39624797 PMC: 11609233. DOI: 10.1016/j.xops.2024.100624.


Increased inflammatory mediators in the ocular surface tissue in keratoconus.

Santos A, Filho J, Cenedeze M, Hiyane M, Amano M, Cruz M Mol Vis. 2024; 30:279-288.

PMID: 39563679 PMC: 11575844.